Research
Showing of 166 results
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
UH Harrington Heart & Vascular Institute at UH Portage Medical Center Study Shows Improved Patient Cardiovascular Outcomes
Enhanced access to cardiovascular care reduces ischemic heart disease mortality in rural Ohio.
International Harrington Prize Awarded to Dr. Owen Witte
2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies.
UH Rainbow Receives Grants from the Society of Critical Care Medicine to Study Severe Bronchiolitis
UH Rainbow Babies & Children’s Hospital has received two grants from SCCM to study the pathobiological factors and mechanistic underpinnings underlying severe bronchiolitis and sepsis.
New Scientific Research Sheds Light on the Role of Vitamins K2 MK-7 and D3 in Alleviating Long COVID Symptoms
A groundbreaking clinical trial conducted by University Hospitals and published in the peer-reviewed journal Nutrients has revealed that a daily dose of vitamin D3 and vitamin K2 MK-7 could help improve symptoms of long COVID.
Research Team from Wesley Center for Immunotherapy at UH Seidman Cancer Center Awarded Top Scoring Abstract Award at the 2025 International Society for Cell and Gene Therapy Annual Meeting
Dr. David Wald and his colleagues selected for their abstract "Development and Clinical Validation of a Less Than One Day CAR T-cell Therapy Manufacturing Process".
Researchers at University Hospitals, Case Western Reserve to begin clinical testing with new, less-invasive technology to screen for esophageal precancer
Study supported by $8 million National Institutes of Health grant.
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.